Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Good morning, and welcome to Mersana Therapeutics First Quarter 2025 ...

Martin Huber; President, Chief Executive Officer, Director; Mersana Therapeutics Inc Brian Deschuytner; Chief Financial Officer, Chief Operating Officer, Senior Vice President; Mersana Therapeutics ...

The median age at symptom onset in the cohort was 55 years, ranging from 16 to 81 years. Data from patients’ initial ...

Berlin as a meeting destination will be showcasing itself and launching new Impact Programme at IMEX Frankfurt from 20 to 22 ...

Market Overview: The acupuncture needle market in Vietnam is witnessing growth, driven by factors such as the increasing popularity of traditional medicine, a focus on holistic health, and a demand ...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, and Aurevia Oy via its Labquality EQAS affiliate (Aurevia), announce a pilot external quality assessment ("EQA") ...

Dermatological Conditions: Dermatological conditions are common in Vietnam, and their prevalence has contributed to the growth of the advanced dermatology drug delivery market. These conditions ...

DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for acute ischemic stroke and preeclampsia, today provided a business update and ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 represents the ...

In this research paper, the authors (Xu et al., 2024) refer to “women” as individuals with the biological capacity for menopause. Gender identity was not collected in this study, and thus, findings ...

A new issue paper from the Action Collaborative on Preventing Sexual Harassment in Higher Education examines the existing ...

Discover the top 5 AI video generators of 2025, ranked for their power, flexibility, and value. Compare features, pricing, ...